Co-evolution of Human Leukocyte Antigen (HLA) Class I Ligands with Killer-Cell Immunoglobulin-Like Receptors (KIR) in a Genetically Diverse Population of Sub-Saharan Africans

PLoS Genetics

Volumn 9, Issue 10, 2013, Pages

  Norman, Paul J ^a   Hollenbach, Jill A ^b   Nemat Gorgani, Neda ^a   Guethlein, Lisbeth A ^a   Hilton, Hugo G ^a   Pando, Marcelo J ^a   Koram, Kwadwo A ^c   Riley, Eleanor M ^d   Abi Rached, Laurent ^a,e   Parham, Peter ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c University of Ghana   (Ghana)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; EPITOPE; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA B35 ANTIGEN; HLA B53 ANTIGEN; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; PROTEIN LILRB1; UNCLASSIFIED DRUG; HLA ANTIGEN; LIGAND;

ALLOTYPE; ARTICLE; CELL INTERACTION; CELL SURFACE; CENTROMERE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GHANA; HAPLOTYPE; HUMAN; HUMAN CELL; KIR3DL1 GENE; MOLECULAR EVOLUTION; NATURAL KILLER CELL; NEWBORN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; AFRICA SOUTH OF THE SAHARA; BLACK PERSON; CHILD; GENETIC SELECTION; GENETICS; IMMUNOLOGY; MALARIA; MOLECULAR GENETICS; PATHOLOGY; POPULATION GENETICS;

AFRICA SOUTH OF THE SAHARA; AFRICAN CONTINENTAL ANCESTRY GROUP; CHILD; EVOLUTION, MOLECULAR; GENETICS, POPULATION; HAPLOTYPES; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LIGANDS; MALARIA; MOLECULAR SEQUENCE DATA; RECEPTORS, KIR; SELECTION, GENETIC;

EID: 84887292436     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003938     Document Type: Article

References (121)

1. Zinkernagel RM, Doherty PC, (1974) Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248: 701-702.
2. Colonna M, Samaridis J, (1995) Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268: 405-408.
3. Moffett A, Loke C, (2006) Immunology of placentation in eutherian mammals. Nat Rev Immunol 6: 584-594.
4. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, et al. (1987) The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329: 512-518.
5. Fadda L, Borhis G, Ahmed P, Cheent K, Pageon SV, et al. (2010) Peptide antagonism as a mechanism for NK cell activation. Proc Natl Acad Sci U S A 107: 10160-10165.
6. Germain RN, (1994) MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76: 287-299.
7. Abi Rached L, McDermott MF, Pontarotti P, (1999) The MHC big bang. Immunol Rev 167: 33-44.
8. Barreiro LB, Quintana-Murci L, (2010) From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat Rev Genet 11: 17-30.
9. Trowsdale J, (2011) The MHC, disease and selection. Immunol Lett 137: 1-8.
10. Adams EJ, Parham P, (2001) Species-specific evolution of MHC class I genes in the higher primates. Immunol Rev 183: 41-64.
11. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, et al. (2004) Gene map of the extended human MHC. Nat Rev Genet 5: 889-899.
12. Robinson J, Mistry K, McWilliam H, Lopez R, Marsh SG, (2010) IPD-the Immuno Polymorphism Database. Nucleic Acids Res 38: D863-869.
13. Solberg OD, Mack SJ, Lancaster AK, Single RM, Tsai Y, et al. (2008) Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies. Hum Immunol 69: 443-464.
14. Belich MP, Madrigal JA, Hildebrand WH, Zemmour J, Williams RC, et al. (1992) Unusual HLA-B alleles in two tribes of Brazilian Indians. Nature 357: 326-329.
15. Watkins DI, McAdam SN, Liu X, Strang CR, Milford EL, et al. (1992) New recombinant HLA-B alleles in a tribe of South American Amerindians indicate rapid evolution of MHC class I loci. Nature 357: 329-333.
16. Kloverpris HN, Harndahl M, Leslie AJ, Carlson JM, Ismail N, et al. (2012) HIV control through a single nucleotide on the HLA-B locus. J Virol 86: 11493-11500.
17. Tynan FE, Elhassen D, Purcell AW, Burrows JM, Borg NA, et al. (2005) The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation. J Exp Med 202: 1249-1260.
18. Vivian JP, Duncan RC, Berry R, O'Connor GM, Reid HH, et al. (2011) Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature 479: 401-405.
19. Winter CC, Long EO, (1997) A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J Immunol 158: 4026-4028.
20. Garcia KC, Adams JJ, Feng D, Ely LK, (2009) The molecular basis of TCR germline bias for MHC is surprisingly simple. Nat Immunol 10: 143-147.
21. Marrack P, Scott-Browne JP, Dai S, Gapin L, Kappler JW, (2008) Evolutionarily conserved amino acids that control TCR-MHC interaction. Annu Rev Immunol 26: 171-203.
22. Gao GF, Tormo J, Gerth UC, Wyer JR, McMichael AJ, et al. (1997) Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature 387: 630-634.
23. Willcox BE, Thomas LM, Bjorkman PJ, (2003) Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol 4: 913-919.
24. Cosman D, Fanger N, Borges L, Kubin M, Chin W, et al. (1997) A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7: 273-282.
25. Moretta L, Moretta A, (2004) Killer immunoglobulin-like receptors. Curr Opin Immunol 16: 626-633.
26. Boyington JC, Brooks AG, Sun PD, (2001) Structure of killer cell immunoglobulin-like receptors and their recognition of the class I MHC molecules. Immunol Rev 181: 66-78.
27. Peruzzi M, Wagtmann N, Long EO, (1996) A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705. J Exp Med 184: 1585-1590.
28. Bashirova AA, Martin MP, McVicar DW, Carrington M, (2006) The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 7: 277-300.
29. Parham P, Moffett A, (2013) Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol 13 (2) ():: 133-44.
30. Hilton HG, Vago L, Older Aguilar AM, Moesta AK, Graef T, et al. (2012) Mutation at Positively Selected Positions in the Binding Site for HLA-C Shows That KIR2DL1 Is a More Refined but Less Adaptable NK Cell Receptor Than KIR2DL3. J Immunol 189: 1418-1430.
31. Moesta AK, Norman PJ, Yawata M, Yawata N, Gleimer M, et al. (2008) Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J Immunol 180: 3969-3979.
32. Thananchai H, Gillespie G, Martin MP, Bashirova A, Yawata N, et al. (2007) Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol 178: 33-37.
33. Riley EM, Stewart VA, (2013) Immune mechanisms in malaria: new insights in vaccine development. Nat Med 19: 168-178.
34. Parham P, Norman PJ, Abi-Rached L, Guethlein LA, (2011) Variable NK cell receptors exemplified by human KIR3DL1/S1. J Immunol 187: 11-19.
35. Norman PJ, Abi-Rached L, Gendzekhadze K, Korbel D, Gleimer M, et al. (2007) Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat Genet 39: 1092-1099.
36. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, et al. (1997) Human diversity in killer cell inhibitory receptor genes. Immunity 7: 753-763.
37. Wilson MJ, Torkar M, Haude A, Milne S, Jones T, et al. (2000) Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci U S A 97: 4778-4783.
38. Abi-Rached L, Moesta AK, Rajalingam R, Guethlein LA, Parham P, (2010) Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells. PLoS Genet 6: e1001192.
39. Hirayasu K, Ohashi J, Kashiwase K, Hananantachai H, Naka I, et al. (2012) Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA. PLoS Pathog 8: e1002565.
40. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, et al. (2011) HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476: 96-100.
41. Charoudeh HN, Terszowski G, Czaja K, Gonzalez A, Schmitter K, et al. (2012) Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection. Eur J Immunol 43 (2) ():: 480-7.
42. Seich Al Basatena NK, Macnamara A, Vine AM, Thio CL, Astemborski J, et al. (2011) KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. PLoS Pathog 7: e1002270.
43. Venstrom JM, Pittari G, Gooley TA, Chewning JH, Spellman S, et al. (2012) HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. N Engl J Med 367: 805-816.
44. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, et al. (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872-874.
45. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, et al. (2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 39: 733-740.
46. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CW, Carrington M, et al. (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200: 957-965.
47. Norman PJ, Stephens HA, Verity DH, Chandanayingyong D, Vaughan RW, (2001) Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics 52: 195-205.
48. Hollenbach JA, Nocedal I, Ladner MB, Single RM, Trachtenberg EA, (2012) Killer cell immunoglobulin-like receptor (KIR) gene content variation in the HGDP-CEPH populations. Immunogenetics 64 (10) ():: 719-37.
49. Gendzekhadze K, Norman PJ, Abi-Rached L, Graef T, Moesta AK, et al. (2009) Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands. Proc Natl Acad Sci U S A 106: 18692-18697.
50. Vierra-Green C, Roe D, Hou L, Hurley CK, Rajalingam R, et al. (2012) Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individuals. PLoS One 7: e47491.
51. Yawata M, Yawata N, Draghi M, Little AM, Partheniou F, et al. (2006) Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 203: 633-645.
52. Middleton D, Meenagh A, Gourraud PA, (2007) KIR haplotype content at the allele level in 77 Northern Irish families. Immunogenetics 59: 145-158.
53. Henn BM, Cavalli-Sforza LL, Feldman MW, (2012) The great human expansion. Proc Natl Acad Sci U S A 109: 17758-17764.
54. Oppenheimer S, (2012) Out-of-Africa, the peopling of continents and islands: tracing uniparental gene trees across the map. Philos Trans R Soc Lond B Biol Sci 367: 770-784.
55. Gomez-Lozano N, Gardiner CM, Parham P, Vilches C, (2002) Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. Immunogenetics 54: 314-319.
56. Gourraud PA, Meenagh A, Cambon-Thomsen A, Middleton D, (2010) Linkage disequilibrium organization of the human KIR superlocus: implications for KIR data analyses. Immunogenetics 62: 729-740.
57. Norman PJ, Abi-Rached L, Gendzekhadze K, Hammond JA, Moesta AK, et al. (2009) Meiotic recombination generates rich diversity in NK cell receptor genes, alleles, and haplotypes. Genome Res 19: 757-769.
58. Pando MJ, Gardiner CM, Gleimer M, McQueen KL, Parham P, (2003) The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol 171: 6640-6649.
59. Sharma D, Bastard K, Guethlein LA, Norman PJ, Yawata N, et al. (2009) Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402. J Immunol 183: 4569-4582.
60. Adeyemo AA, Chen G, Chen Y, Rotimi C, (2005) Genetic structure in four West African population groups. BMC Genet 6: 38.
61. Bryc K, Auton A, Nelson MR, Oksenberg JR, Hauser SL, et al. (2010) Genome-wide patterns of population structure and admixture in West Africans and African Americans. Proc Natl Acad Sci U S A 107: 786-791.
62. Watterson GA, (1978) The homozygosity test of neutrality. Genetics 88: 405-417.
63. Salamon H, Klitz W, Easteal S, Gao X, Erlich HA, et al. (1999) Evolution of HLA class II molecules: Allelic and amino acid site variability across populations. Genetics 152: 393-400.
64. Salter RD, Benjamin RJ, Wesley PK, Buxton SE, Garrett TP, et al. (1990) A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature 345: 41-46.
65. Sanjanwala B, Draghi M, Norman PJ, Guethlein LA, Parham P, (2008) Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1. J Immunol 181: 6293-6300.
66. Allsopp CE, Hill AV, Kwiatkowski D, Hughes A, Bunce M, et al. (1991) Sequence analysis of HLA-Bw53, a common West African allele, suggests an origin by gene conversion of HLA-B35. Hum Immunol 30: 105-109.
67. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P, (1995) The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 181: 1133-1144.
68. Cao K, Moormann AM, Lyke KE, Masaberg C, Sumba OP, et al. (2004) Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens 63: 293-325.
69. Jones DC, Kosmoliaptsis V, Apps R, Lapaque N, Smith I, et al. (2011) HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. J Immunol 186: 2990-2997.
70. Mantel N, (1967) The detection of disease clustering and a generalized regression approach. Cancer Res 27: 209-220.
71. Saper MA, Bjorkman PJ, Wiley DC, (1991) Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol 219: 277-319.
72. Fadda L, O'Connor GM, Kumar S, Piechocka-Trocha A, Gardiner CM, et al. (2011) Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules. J Virol 85: 5970-5974.
73. Bari R, Bell T, Leung WH, Vong QP, Chan WK, et al. (2009) Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine 245. Blood 114: 5182-5190.
74. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR, (2011) Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 39: D913-919.
75. Henn BM, Gignoux CR, Jobin M, Granka JM, Macpherson JM, et al. (2011) Hunter-gatherer genomic diversity suggests a southern African origin for modern humans. Proc Natl Acad Sci U S A 108: 5154-5162.
76. Single RM, Martin MP, Gao X, Meyer D, Yeager M, et al. (2007) Global diversity and evidence for coevolution of KIR and HLA. Nat Genet 39: 1114-1119.
77. Mintseris J, Weng Z, (2005) Structure, function, and evolution of transient and obligate protein-protein interactions. Proc Natl Acad Sci U S A 102: 10930-10935.
78. Allison AC, (1954) Protection afforded by sickle-cell trait against subtertian malareal infection. Br Med J 1: 290-294.
79. Hill AV, Elvin J, Willis AC, Aidoo M, Allsopp CE, et al. (1992) Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360: 434-439.
80. Wagner G, Koram K, McGuinness D, Bennett S, Nkrumah F, et al. (1998) High incidence of asymptomatic malara infections in a birth cohort of children less than one year of age in Ghana, detected by multicopy gene polymerase chain reaction. Am J Trop Med Hyg 59: 115-123.
81. Hill AV, (2012) Evolution, revolution and heresy in the genetics of infectious disease susceptibility. Philos Trans R Soc Lond B Biol Sci 367: 840-849.
82. Leffler EM, Gao Z, Pfeifer S, Segurel L, Auton A, et al. (2013) Multiple Instances of Ancient Balancing Selection Shared Between Humans and Chimpanzees. Science 339 (6127) ():: 1578-82.
83. Tishkoff SA, Reed FA, Friedlaender FR, Ehret C, Ranciaro A, et al. (2009) The genetic structure and history of Africans and African Americans. Science 324: 1035-1044.
84. Yang Z, Bjorkman PJ, (2008) Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor. Proc Natl Acad Sci U S A 105: 10095-10100.
85. Lanier LL, (2008) Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 8: 259-268.
86. Adjei AA, Armah HB, Gbagbo F, Boamah I, Adu-Gyamfi C, et al. (2008) Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa. BMC Infect Dis 8: 111.
87. Bristow BN, O'Keefe KA, Shafir SC, Sorvillo FJ, (2011) Congenital cytomegalovirus mortality in the United States, 1990-2006. PLoS Negl Trop Dis 5: e1140.
88. Munson PJ, (1980) Archaeology and Prehistoric Origins of the Ghana Empire. Journal of African History 21: 457-466.
89. Salm SJ, Falola T (2002) Culture and Customs of Ghana. Westport, CT: ABC-CLIO/Greenwood.
90. de Filippo C, Barbieri C, Whitten M, Mpoloka SW, Gunnarsdottir ED, et al. (2011) Y-chromosomal variation in sub-Saharan Africa: insights into the history of Niger-Congo groups. Mol Biol Evol 28: 1255-1269.
91. Veeramah KR, Connell BA, Pour NA, Powell A, Plaster CA, et al. (2010) Little genetic differentiation as assessed by uniparental markers in the presence of substantial language variation in peoples of the Cross River region of Nigeria. BMC Evol Biol 10: 92.
92. Marsh SG, Parham P, Dupont B, Geraghty DE, Trowsdale J, et al. (2003) Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Immunogenetics 55: 220-226.
93. Pyo CW, Guethlein LA, Vu Q, Wang R, Abi-Rached L, et al. (2010) Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus. PLoS One 5: e15115.
94. Stephens M, Donnelly P, (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73: 1162-1169.
95. Kijak GH, Walsh AM, Koehler RN, Moqueet N, Eller LA, et al. (2009) HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic cluster. Tissue Antigens 73: 262-269.
96. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851-861.
97. Pritchard JK, Stephens M, Donnelly P, (2000) Inference of population structure using multilocus genotype data. Genetics 155: 945-959.
98. Tajima F, (1989) Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123: 585-595.
99. Rozas J, Sanchez-DelBarrio JC, Messeguer X, Rozas R, (2003) DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19: 2496-2497.
100. Hudson RR, (2002) Generating samples under a Wright-Fisher neutral model of genetic variation. Bioinformatics 18: 337-338.
101. Hedrick PW, Thomson G, (1983) Evidence for balancing selection at HLA. Genetics 104: 449-456.
102. Slatkin M, (1994) An exact test for neutrality based on the Ewens sampling distribution. Genet Res 64: 71-74.
103. Lancaster AK, Single RM, Solberg OD, Nelson MP, Thomson G, (2007) PyPop update-a software pipeline for large-scale multilocus population genomics. Tissue Antigens 69 Suppl 1: 192-197.
104. Yang Z, (2007) PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol 24: 1586-1591.
105. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739.
106. Ronquist F, Teslenko M, van der Mark P, Ayres DL, Darling A, et al. (2012) MrBayes 3.2: efficient Bayesian phylogenetic inference and model choice across a large model space. Syst Biol 61: 539-542.
107. Paradis E, (2010) pegas: an R package for population genetics with an integrated-modular approach. Bioinformatics 26: 419-420.
108. Templeton AR, Crandall KA, Sing CF, (1992) A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping and DNA sequence data. III. Cladogram estimation. Genetics 132: 619-633.
109. Nei M (1987) Molecular Evolutionary Genetics: Columbia University Press.
110. Popescu AA, Huber KT, Paradis E, (2012) ape 3.0: New tools for distance-based phylogenetics and evolutionary analysis in R. Bioinformatics 28: 1536-1537.
111. R Development Core Team (2008) A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria.
112. Shilling HG, Guethlein LA, Cheng NW, Gardiner CM, Rodriguez R, et al. (2002) Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol 168: 2307-2315.
113. Graef T, Moesta AK, Norman PJ, Abi-Rached L, Vago L, et al. (2009) KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J Exp Med 206: 2557-2572.
114. Hou L, Jiang B, Chen M, Ng J, Hurley CK, (2011) The characteristics of allelic polymorphism in killer-immunoglobulin-like receptor framework genes in African Americans. Immunogenetics 63: 549-559.
115. Gomez-Lozano N, Trompeter HI, de Pablo R, Estefania E, Uhrberg M, et al. (2007) Epigenetic silencing of potentially functional KIR2DL5 alleles: Implications for the acquisition of KIR repertoires by NK cells. Eur J Immunol 37: 1954-1965.
116. Goodridge JP, Witt CS, Christiansen FT, Warren HS, (2003) KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J Immunol 171: 1768-1774.
117. VandenBussche CJ, Mulrooney TJ, Frazier WR, Dakshanamurthy S, Hurley CK, (2009) Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule. Genes Immun 10: 162-173.
118. Fan QR, Mosyak L, Winter CC, Wagtmann N, Long EO, et al. (1997) Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors. Nature 389: 96-100.
119. Rudolph MG, Stanfield RL, Wilson IA, (2006) How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24: 419-466.
120. Hughes AL, Nei M, (1988) Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature 335: 167-170.
121. Parham P, Lomen CE, Lawlor DA, Ways JP, Holmes N, et al. (1988) Nature of polymorphism in HLA-A,-B, and-C molecules. Proc Natl Acad Sci U S A 85: 4005-4009.